Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TDS, FVT

BroadJump Introduces Dynamic Spend Intelligence at IDN Fall Summit 2018


DALLAS, Sept. 17, 2018 /PRNewswire/ -- BroadJump, the leader in comparative analytics for the healthcare industry, is introducing its new expense management platform at the IDN Fall Summit in Phoenix, Arizona on September 17. Dynamic Spend Intelligence provides a web-based, centralized view of all non-labor expense, along with category specific, comparable Key Performance Indicators (KPIs), enabling healthcare systems and facilities to easily identify areas for expense management improvement.

Multiple data sources in a single dashboard
Dynamic Spend Intelligence consolidates purchase data from multiples sources for supplies, pharmaceuticals, procedures, purchased services and capital expenses, combining them into a single dashboard. BroadJump clients are able to see high-level trends and comparative summaries, and then navigate down to line-item detail as needed, all from one application. "IDN Fall Summit attendees know the challenges of tracking expense data across multiple vendors, ERP systems and pharmacy wholesalers. Dynamic Spend Intelligence simplifies data access from all these sources and provides relevant analytics that quickly and easily identify opportunities for improvement," says BroadJump Chief Operating Officer Greg Corban. "We like to call it 'mission control for expense managementtm'".

Dynamic Spend Intelligence enables data mining
Dynamic Spend Intelligence allows the user to mine data by segment, department, general ledger, sourcing category or manufacturer. It integrates seamlessly with BroadJump's entire suite of comparative analytics applications, including AutoPricer and ProcedureProfiler, to provide additional visibility into opportunities within an organization's purchased supplies and services. BroadJump representatives will be in attendance at this year's IDN Fall Summit to answer questions and provide demonstrations of Dynamic Spend Intelligence.

For more information on Dynamic Spend Intelligence, please visit our website.

About BroadJump
BroadJump is a comparative analytics company that delivers transparency to healthcare expense management. Using its Web-based applications, BroadJump's clients gain access to comprehensive, unbiased insights that result in improved efficiency and care. For more information, please visit www.BroadJumpLLC.com.

Contact: Craig Premo, [email protected]

 

BroadJump is a comparative analytics company that delivers transparency to healthcare expense management. Using its Web-based applications, BroadJump's clients gain access to comprehensive, unbiased insights that result in improved efficiency and care. For more information, please visit www.BroadJumpLLC.com. (PRNewsfoto/BroadJump)

SOURCE BroadJump


These press releases may also interest you

at 22:16
On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of Science, published a research paper titled "Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system...

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...



News published on and distributed by: